1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Pharmaceutical Analysis & Statistics in North America Countries, September 2016 (p57)

Pharmaceutical Analysis & Statistics in North America Countries, September 2016 (p57)

24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Publishers

1681-1710 of about 6400 reports

Purchase Reports From Reputable Market Research Publishers

Sinusitis - Pipeline Review, H2 2016

Sinusitis - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • September 2016
  • by Global Markets Direct

Sinusitis - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Sinusitis - Pipeline Review, H2 2016’, provides an overview of the Sinusitis pipeline landscape. The report provides comprehensive ...

  • Industries : Therapy, Pharmaceutical, Pathology
  • Countries : United States
Interleukin 17A (Cytotoxic T Lymphocyte Associated Antigen 8 or CTLA8 or IL17A) - Pipeline Review, H2 2016

Interleukin 17A (Cytotoxic T Lymphocyte Associated Antigen 8 or CTLA8 or IL17A) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • September 2016
  • by Global Markets Direct

Interleukin 17A (Cytotoxic T Lymphocyte Associated Antigen 8 or CTLA8 or IL17A) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Interleukin 17A (Cytotoxic T Lymphocyte Associated Antigen ...

  • Industries : Pathology
  • Countries : United States
Gastric Inhibitory Polypeptide Receptor (Glucose Dependent Insulinotropic Polypeptide Receptor or GIPR) - Pipeline Review, H2 2016

Gastric Inhibitory Polypeptide Receptor (Glucose Dependent Insulinotropic Polypeptide Receptor or GIPR) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • September 2016
  • by Global Markets Direct

Gastric Inhibitory Polypeptide Receptor (Glucose Dependent Insulinotropic Polypeptide Receptor or GIPR) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Gastric Inhibitory Polypeptide Recepto ...

  • Industries : Therapy, Pathology
  • Countries : World, United States
Glomerulonephritis - Pipeline Review, H2 2016

Glomerulonephritis - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • September 2016
  • by Global Markets Direct

Glomerulonephritis - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Glomerulonephritis - Pipeline Review, H2 2016’, provides an overview of the Glomerulonephritis pipeline landscape. ...

  • Industries : Pathology, Therapy, Healthcare
  • Countries : United States
Endometriosis - Pipeline Review, H2 2016

Endometriosis - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • September 2016
  • by Global Markets Direct

Endometriosis - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Endometriosis - Pipeline Review, H2 2016’, provides an overview of the Endometriosis pipeline landscape. The report provides ...

  • Industries : Pathology, Healthcare, Therapy, Pharmaceutical
  • Countries : United States
Mammography Equipment - Medical Devices Pipeline Assessment, 2016

Mammography Equipment - Medical Devices Pipeline Assessment, 2016

  • $ 2500
  • Industry report
  • September 2016
  • by GlobalData

Mammography Equipment - Medical Devices Pipeline Assessment, 2016 Summary GlobalData's Medical Devices sector report, “Mammography Equipment - Medical Devices Pipeline Assessment, 2016" provides an overview ...

  • Industries : Diagnostic Imaging, Medical Device, Drug Discovery and Development
  • Countries : United States
Ovarian Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016

Ovarian Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016

  • $ 4000
  • Industry report
  • September 2016
  • by GlobalData

Ovarian Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016 Summary GlobalData's Medical Devices sector report, “Ovarian Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, ...

  • Industries : Cancer, Pathology, Drug Discovery and Development, Pharmaceutical
  • Countries : United States
Liver Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016

Liver Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016

  • $ 4000
  • Industry report
  • September 2016
  • by GlobalData

Liver Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016 Summary GlobalData's Medical Devices sector report, “Liver Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016" ...

  • Industries : Pathology, Cancer, Healthcare, Drug Discovery and Development
  • Countries : United States
Injectable Drug Delivery - Medical Devices Pipeline Assessment, 2016

Injectable Drug Delivery - Medical Devices Pipeline Assessment, 2016

  • $ 4000
  • Industry report
  • September 2016
  • by GlobalData

Injectable Drug Delivery - Medical Devices Pipeline Assessment, 2016 Summary GlobalData's Medical Devices sector report, “Injectable Drug Delivery - Medical Devices Pipeline Assessment, 2016" provides ...

  • Industries : Pharmaceutical
  • Countries : United States
Mitogen Activated Protein Kinase 14 (Cytokine Suppressive Anti Inflammatory Drug Binding Protein or Mitogen Activated Protein Kinase p38 Alpha or MAP Kinase MXI2 or MAX Interacting Protein 2 or Stress Activated Protein Kinase 2a or MAPK14 or EC 2.7.11.24)

Mitogen Activated Protein Kinase 14 (Cytokine Suppressive Anti Inflammatory Drug Binding Protein or Mitogen Activated Protein Kinase p38 Alpha or MAP Kinase MXI2 or MAX Interacting Protein 2 or Stress Activated Protein Kinase 2a or MAPK14 or EC 2.7.11.24)

  • $ 3500
  • Industry report
  • September 2016
  • by Global Markets Direct

Mitogen Activated Protein Kinase 14 (Cytokine Suppressive Anti Inflammatory Drug Binding Protein or Mitogen Activated Protein Kinase p38 Alpha or MAP Kinase MXI2 or MAX Interacting Protein 2 or Stress ...

  • Industries : Therapy, Pathology, Pharmaceutical
  • Countries : United States
Apricus Biosciences Inc

Apricus Biosciences Inc

  • $ 99
  • Company report
  • September 2016
  • by Wright Investors' Service

A textual analysis of the financial results for Apricus Biosciences Inc compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio ...

  • Countries : United States
Vitamin Shoppe, Inc. (VSI) - Financial and Strategic SWOT Analysis Review

Vitamin Shoppe, Inc. (VSI) - Financial and Strategic SWOT Analysis Review

  • $ 125
  • Company report
  • September 2016
  • by GlobalData

Vitamin Shoppe, Inc. (VSI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by ...

  • Industries : OTC
  • Countries : United States
Ionis Pharmaceuticals, Inc. (IONS) - Financial and Strategic SWOT Analysis Review

Ionis Pharmaceuticals, Inc. (IONS) - Financial and Strategic SWOT Analysis Review

  • $ 125
  • Company report
  • September 2016
  • by GlobalData

Ionis Pharmaceuticals, Inc. (IONS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled ...

  • Industries : Pharmaceutical
  • Countries : United States
NPS+ Rheumatoid Arthritis (EU5)

NPS+ Rheumatoid Arthritis (EU5)

  • $ 2668
  • Industry report
  • September 2016
  • by Firstword Pharma

Two leading brands continue to dominate satisfaction scores. Where does your brand rank? Few brands are earning high satisfaction scores in the European rheumatoid arthritis (RA) treatment market, but ...

  • Industries : Therapy
  • Countries : United States
US Lymphedema Market with Focus on the Pneumatic Compression Device (PCD) (2016-2021)

US Lymphedema Market with Focus on the Pneumatic Compression Device (PCD) (2016-2021)

  • $ 850
  • Industry report
  • September 2016
  • by Daedal Research

Scope of the Report The report entitled “US Lymphedema Market with Focus on the Pneumatic Compression Device (PCD) (2016-2021)”, provides analysis of the US lymphedema market, with detailed analysis ...

  • Industries : Pathology
  • Countries : United States
Global Advanced Wound Care Industry

Global Advanced Wound Care Industry

  • $ 4950
  • Industry report
  • September 2016
  • by Global Industry Analysts

This report analyzes the worldwide markets for Advanced Wound Care in US$ Thousand by the following Product Segments: Dressings (Alginate Dressings, Hydrocolloids, Hydrogels, Foam Dressings, Film Dressings, ...

  • Industries : Medical Supply, Therapy
  • Countries : World, United States, Europe, Asia
Hepatitis C: KOL Insight

Hepatitis C: KOL Insight

  • $ 8085
  • Industry report
  • September 2016
  • by Firstword Pharma

As hepatitis C cures multiply, how do experts evaluate the options? Since the launch of Sovaldi (sofosbuvir; Gilead) in 2013, the hepatitis C (HCV) landscape has developed at a rapid pace. The focus ...

  • Industries : Therapy
  • Countries : United States
Type 2 Diabetes Mellitus: KOL Insight 2016

Type 2 Diabetes Mellitus: KOL Insight 2016

  • $ 8085
  • Industry report
  • September 2016
  • by Firstword Pharma

Can top-ranked GLP1 agonists move out of the third-line setting? GLP1 agonists may be the top-ranked type 2 diabetes mellitus (T2DM) treatment according to the American Association of Clinical Endocrinologists ...

  • Industries : Therapy
  • Countries : United States
Global High-Throughput Screening Market - Growth, Trends and Forecasts (2016 - 2021)

Global High-Throughput Screening Market - Growth, Trends and Forecasts (2016 - 2021)

  • $ 4250
  • Industry report
  • September 2016
  • by Mordor Intelligence LLP

The global high-throughput screening (HTS) market is estimated to be USD 16.75 billion in 2016 and is projected to reach USD 22.68 billion by 2021, growing at a CAGR of 6.25% during the forecast period. ...

  • Industries : Drug Discovery and Development
  • Countries : United States
PAIN MANAGEMENT- NEW DISCOVERIES AND TREATMENT OPTIONS IN ABUSE DETERRENT ERA

PAIN MANAGEMENT- NEW DISCOVERIES AND TREATMENT OPTIONS IN ABUSE DETERRENT ERA

  • $ 3500
  • Industry report
  • September 2016
  • by MP Advisors

Rescheduling of Hydrocodone combinations from Class III to Class II, clear-cut regulatory guideline for Abuse Deterrent drug formulation NDA & ANDA (solid oral) filing and CDC guideline for Prescribing ...

  • Industries : Therapy
  • Countries : United States
Analyzing the Global Diabetes Market 2016

Analyzing the Global Diabetes Market 2016

  • $ 1000
  • Industry report
  • September 2016
  • by Aruvian's R'search

Diabetes is a chronic disease in which there are high levels of sugar in the blood. The World Diabetes Foundation estimates that there will be 438 million people with diabetes by the year 2030. Oral anti-diabetics ...

  • Industries : Therapy, Pharmaceutical, Pathology, Chronic Disease
  • Countries : United States, World
Global Monoclonal Antibody Partnering Terms and Agreements 2010-2016: Deal trends, players and financials

Global Monoclonal Antibody Partnering Terms and Agreements 2010-2016: Deal trends, players and financials

  • $ 2995
  • Industry report
  • September 2016
  • by Currentpartnering

The Global Monoclonal antibody Partnering Terms and Agreements 2010 to 2016: Deal trends, players, financials and forecasts report provides a detailed understanding and analysis of how and why companies ...

  • Industries : Therapy, Pharmaceutical, Pathology, Oncology, Biotechnology, Healthcare
  • Countries : United States
Global Cancer Monoclonal Antibody Partnering Terms and Agreements 2010-2016: Deal trends, players and financials

Global Cancer Monoclonal Antibody Partnering Terms and Agreements 2010-2016: Deal trends, players and financials

  • $ 2995
  • Industry report
  • September 2016
  • by Currentpartnering

The Global Cancer Monoclonal Antibody Partnering 2010-2016: Deal trends, players, financials and forecasts report provides an understanding and access to the cancer monoclonal antibody partnering deals ...

  • Industries : Therapy, Cancer, Oncology, Pharmaceutical, Pathology, Biotechnology
  • Countries : United States
Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation

Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation

  • $ 6995
  • Industry report
  • September 2016
  • by GBI Research

Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation Summary Glioblastoma multiforme (GBM) is a grade IV tumor that arises from astrocytes. It is ...

  • Industries : Cancer, Pathology, Therapy
  • Countries : World, United States
US Drug Eluting Sinus Stent (DESS) Market: Size, Trends & Forecasts (2016-2021)

US Drug Eluting Sinus Stent (DESS) Market: Size, Trends & Forecasts (2016-2021)

  • $ 900
  • Industry report
  • September 2016
  • by Daedal Research

Scope of the Report The report entitled “US Drug Eluting Sinus Stent (DESS) Market: Size, Trends & Forecasts (2016-2021)”, provides analysis of the US DESS market, with detailed analysis of market ...

  • Industries : OTC
  • Countries : United States
CrystalGenomics, Inc. - Product Pipeline Review - 2016

CrystalGenomics, Inc. - Product Pipeline Review - 2016

  • $ 1500
  • Company report
  • August 2016
  • by Global Markets Direct

CrystalGenomics, Inc. - Product Pipeline Review - 2016 Summary Global Markets Direct’s, ‘CrystalGenomics, Inc. - Product Pipeline Review, 2016’, provides an overview of the CrystalGenomics, Inc.’s ...

  • Industries : Research and Development, Therapy
  • Countries : United States, World
Visceral Pain - Pipeline Review, H2 2016

Visceral Pain - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • August 2016
  • by Global Markets Direct

Visceral Pain - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Visceral Pain - Pipeline Review, H2 2016’, provides an overview of the Visceral Pain pipeline landscape. The report provides ...

  • Industries : Chronic Disease, Pathology
  • Countries : World, United States
Pruritus - Pipeline Review, H2 2016

Pruritus - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • August 2016
  • by Global Markets Direct

Pruritus - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Pruritus - Pipeline Review, H2 2016’, provides an overview of the Pruritus pipeline landscape. The report provides comprehensive ...

  • Industries : Pathology, Healthcare, Therapy
  • Countries : United States
Fabry Disease - Pipeline Review, H2 2016

Fabry Disease - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • August 2016
  • by Global Markets Direct

Fabry Disease - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Fabry Disease - Pipeline Review, H2 2016’, provides an overview of the Fabry Disease pipeline landscape. The report provides ...

  • Industries : Pathology, Therapy, Pharmaceutical, Mental Health, Healthcare
  • Countries : United States, World, Europe
Batten Disease - Pipeline Review, H2 2016

Batten Disease - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • August 2016
  • by Global Markets Direct

Batten Disease - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Batten Disease - Pipeline Review, H2 2016’, provides an overview of the Batten Disease pipeline landscape. The report provides ...

  • Industries : Mental Health, Pathology
  • Countries : United States

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.